ICD-10-CM Billable Code

N90.812

Female genital mutilation Type II status

Clinical Classification Guidelines

Inclusion Terms

  • Clitorectomy with excision of labia minora status
  • Female genital cutting Type II status

Medical Intelligence & Overview

Female genital mutilation (FGM) encompasses all procedures involving the partial or total removal of the external female genitalia or other injury to female genital organs for non-medical reasons. Specifically, FGM Type II involves the removal of the clitoris (clitorectomy) along with the excision of the labia minora. This practice is rooted in cultural, religious, or social reasons and is recognized internationally as a violation of human rights and a harmful procedure with potential long-term health consequences.

Causes & Symptoms

Clinical Causes: Cultural traditions within certain communities Rite of passage or social acceptance markers Perceived social or religious requirements Attempts to control female sexuality Lack of awareness of health risks associated with the procedure

Key Symptoms: Immediate pain and swelling post-procedure Hemorrhage or bleeding Infection at the site of mutilation Urinary problems or difficulty urinating Chronic pain or discomfort in the genital area Formation of scars or keloids Menstrual difficulties Potential complications during childbirth Psychological trauma, including anxiety and depression

Diagnostic & Treatment

Diagnosis Path: Diagnosis of FGM Type II is primarily based on clinical examination and patient history. Healthcare providers look for signs such as removal of the clitoris and labia minora, often accompanied by scarring or other anatomical changes. Medical professionals may also inquire about the patient's cultural background, history of mutilation procedures, and related health issues to confirm and understand the extent of the condition.

Treatment Protocols: Management of FGM-related health issues focuses on addressing specific complications. This may include surgical procedures to reconstruct or modify the genital area, treatment for infections, and psychological support. It is essential for healthcare providers to approach care with sensitivity and awareness of the cultural context, emphasizing respectful communication and patient-centered strategies. Preventive efforts mainly involve community education to eradicate the practice and provide support for affected individuals.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N90.812 a billable ICD-10 code?
Yes, N90.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N90.812?
Clinical documentation must specify the nature of Female genital mutilation Type II status and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

genital mutilation female